Genertec Universal Medical Group Co Ltd
Genertec Universal Medical Group Co Ltd operates in the healthcare facilities and services sector, providing medical services and related healthcare solutions.
Business. Genertec Universal Medical Group Co Ltd (2666.HK) is a healthcare services and equipment company primarily engaged in biotechnology activities within the healthcare facilities and services industry. The firm operates on a service-revenue model and is headquartered in China. It is listed on the Hong Kong Stock Exchange under the ticker symbol 2666.HK. Specific details regarding operating segments and geographic revenue mix are not available.
Analyst recommendations
2 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Genertec Universal Medical Group Co Ltd (2666.HK) is a healthcare services and equipment company primarily engaged in biotechnology activities within the healthcare facilities and services industry. The firm operates on a service-revenue model and is headquartered in China. It is listed on the Hong Kong Stock Exchange under the ticker symbol 2666.HK. Specific details regarding operating segments and geographic revenue mix are not available.
Genertec Universal Medical Group Co Ltd has a basic and diluted share count of 2,014,204,924 shares outstanding, indicating no dilution from potential share issuance. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents.
Profitability and return metrics are not available for comparison against industry benchmarks, as the valuation snapshot does not provide relevant data. The company's performance in terms of return on invested capital (ROIC), operating margins, and other key profitability indicators remains unquantified.
The company's revenue concentration and geographic exposure are not disclosed in the available data, making it difficult to assess the risk associated with its segments or regions.
The company's growth trajectory is not quantified in the available data, as no numeric deltas or revenue history are provided in the outlook. Analysts have provided a mean price target of 6.90 CNY, with a mean recommendation of 1.50 (1=strong buy, 5=strong sell), indicating a generally positive outlook.
The company's risk assessment indicates low dilution risk, but liquidity risk could not be assessed due to missing balance-sheet data and no going-concern language in source documents. No dilution sources are disclosed in the available data.
Recent events, including filings and transcripts, are not disclosed in the available data, limiting the ability to assess the company's recent developments.
- The company has no dilution from potential share issuance, with basic and diluted shares outstanding being equal.
- Analysts have provided a positive outlook, with a mean price target of 6.90 CNY and a mean recommendation of 1.50.
- Liquidity risk could not be assessed due to missing balance-sheet data and no going-concern language in source documents.
- Profitability and return metrics are not available for comparison against industry benchmarks.
- The company's growth trajectory and revenue history are not quantified in the available data.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Revenue ¥14.94B, +9,3% YoY; Operating income +5,7% YoY.
- ▍Revenue ¥14.94B, +9,3% YoY
- ▍Operating income +5,7% YoY
- ▍Net income +5,0% YoY
- ▍Free cash flow +51,5% YoY
- ▍Net margin 14.8%
Revenue ¥13.66B, +0,1% YoY; Operating income +1,1% YoY.
- ▍Revenue ¥13.66B, +0,1% YoY
- ▍Operating income +1,1% YoY
- ▍Net income −0,3% YoY
- ▍Free cash flow −18,8% YoY
- ▍Net margin 15.4%
Revenue ¥13.65B, +13,1% YoY; Operating income +6,4% YoY.
- ▍Revenue ¥13.65B, +13,1% YoY
- ▍Operating income +6,4% YoY
- ▍Net income +7,7% YoY
- ▍Free cash flow −8,3% YoY
- ▍Net margin 15.5%
Revenue ¥12.07B, +21,8% YoY; Operating income +0,7% YoY.
- ▍Revenue ¥12.07B, +21,8% YoY
- ▍Operating income +0,7% YoY
- ▍Net income +0,6% YoY
- ▍Free cash flow −10,3% YoY
- ▍Net margin 16.2%
Revenue ¥9.91B; Operating income ¥2.71B.
- ▍Revenue ¥9.91B
- ▍Operating income ¥2.71B
- ▍Net margin 19.6%
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 1,12 |
| Revenue | —no estimate | —no estimate | 9,8B CNY |
| Operating income | —no estimate | —no estimate | 3,1B CNY |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Genertec Universal Medical Group Co Ltd Market data — financials · 2026-05-26
- Genertec Universal Medical Group Co Ltd Market data — analyst estimates · 2026-05-26
Ownership & reference
Leadership
- Qi XiaChief Executive Officer, Executive Director
- Shisu ChenExecutive Chairman of the Board
- Wenbing WangChief Executive Officer, Executive Director